PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Research Spotlight: Study reveals an unexpected role for protein aggregates in brain disease

Researchers from Mass General Brigham release a new study linking protein aggregation to altered RNA processing in genetic forms of neurodegeneration

2025-07-17
(Press-News.org) Raghu R. Chivukula, MD, PhD, a physician-investigator in the Departments of Medicine & Surgery and the Center for Genomic Medicine at Massachusetts General Hospital and Harvard Medical School, is the senior author of a paper published in Science, “Polyglycine-mediated aggregation of FAM98B disrupts tRNA processing in GGC repeat disorders.”
 

Q: How would you summarize your study for a lay audience? Neurodegenerative disorders, such as Alzheimer’s disease and Parkinson’s disease, are devastating and incurable diseases. Although many neurodegenerative diseases are characterized by abnormal protein aggregation in the brain, a limited understanding of whether and how aggregated proteins cause brain cell dysfunction and death represents a major barrier to developing effective treatments.

Inspired by similar approaches in cardiovascular disease and cancer, we focused on rare genetic forms of neurodegeneration as a powerful way to uncover fundamental mechanisms tying protein aggregation to brain disease. Our work unexpectedly linked protein aggregation in genetic forms of neurodegeneration to disrupted processing of transfer RNAs (tRNAs), revealing an important mechanism that might be therapeutically targeted in these disorders.
 

Q: What question were you investigating? We became interested in genetic forms of neurodegeneration caused by GGC trinucleotide repeat expansions (DNA sequence mutations caused by copying this 3-letter sequence too many times in a row). These mutations produce aggregation-prone proteins with long stretches of a single repeated amino acid (glycine). Interestingly, although these “polyglycine”-containing protein aggregates are detectable in many tissue and cell types of affected patients, GGC repeat expansion disorders seem to cause disease only in the central nervous system.

We wanted to understand exactly what polyglycine aggregates do to cells and why they are selectively toxic to cells in the brain.
 

Q: What methods or approach did you use? We employed a biochemistry-based approach to produce polyglycine proteins in cultured cells and to purify the resultant protein aggregates. Then we used mass spectrometry, which measures the amounts of different molecules in a sample, to comprehensively catalog the set of host cell proteins that are recruited into these aggregates and thereby depleted from cells.

We went on to study the consequences of polyglycine aggregation on RNA processing in cultured cells, confirmed our results in human disease tissues samples, and developed mouse models to functionally assess the consequences of tRNA processing defects in the brain.
 

Q: What did you find? We discovered that polyglycine aggregates, both in cultured cells and in human patients, specifically recruit the tRNA ligase complex (tRNA-LC), a group of proteins which is required for processing spliced tRNAs. Notably, mutations in other tRNA splicing genes also cause early-onset neurodegenerative diseases similar to GGC repeat expansion disorders. We found that aggregation of the tRNA-LC leads to misprocessed tRNAs in cultured cells as well as patient brain samples. Moreover, mice in which we depleted the tRNA-LC in the brain developed neurodegeneration and motor coordination deficits similar to those seen in GGC repeat disorders.
 

Q: What are the implications? Our work reveals a new and unexpected link between protein aggregation and RNA processing disorders in GGC repeat diseases.

The striking similarities between GGC repeat disorders and previously described tRNA splicing disorders suggests polyglycine-dependent tRNA splicing disruption may be an important mechanism underlying selective neuronal death. Importantly, our findings also establish proof-of-concept that interfering with tRNA-LC aggregation may protect cells from the pathogenic effects of GGC repeat expansions.
 

Q: What are the next steps? Our laboratory is now actively working to understand the cellular and molecular consequences in vivo of altered tRNA splicing in the brain. We are very interested in developing therapeutic strategies that can block this pathogenic mechanism in neurodegenerative GGC repeat disorders.

 

Authorship: In addition to Chivukula, Mass General Brigham authors include Jason Yang, Yunhan Xu, David R. Ziehr, Max L. Valenstein, Jack R. Bush, Kate Rutter, Maheswaran Kesavan, and Ricardo Mouro Pinto.

Paper cited: Yang, J., et al. “Polyglycine-mediated aggregation of FAM98B disrupts tRNA processing in GGC repeat disorders.” Science. DOI: 10.1126/science.ado2403.

Funding: This work was supported by grants from the Fannie and John Hertz Foundation, the Parker B. Francis Foundation, the National Institute of Diabetes and Digestive and Kidney Diseases (5K08DK129824), the National Institutes of Health (5T32GM007753, R01NS126420), the Medical Research Future Fund, the National Institute of General Medicine Science (5R35GM118135), the Burroughs Welcome Fund, the MGH Department of Surgery Donahoe Catalyst Award, the Chen Institute MGH Department of Medicine Transformative Scholar Award, and the Smith Family Award for Excellence in Biomedical Research.

Disclosures: None

 

END


ELSE PRESS RELEASES FROM THIS DATE:

UK Government and UK Research and Innovation join forces to launch multi-billion-pound compute roadmap

2025-07-17
Quicker health diagnoses, smarter energy supplies, tackling climate change and improved public service delivery – just some huge potential benefits of the new compute roadmap, launched by DSIT and UKRI. The roadmap heralds a significant increase in publicly accessible compute capacity. Investments include up to £2 billion to deliver a holistic and user-centred compute ecosystem with  £1 billion to expand the AI Research Resource 20-fold by 2030. It also provides up to £750 million for UKRI to invest in a new national supercomputing service at Edinburgh. UKRI is further ...

New study in JAMA Network Open shows current approaches to assessing preeclampsia risk are failing the majority of pregnant moms

2025-07-17
South San Francisco, CA (July 17, 2025) - A new study sponsored by Mirvie, which is the first to evaluate U.S. Preventive Services Task Force (USPSTF) guidelines for preeclampsia risk and aspirin prescription in a single, nationally representative, prospective population, found while high-risk factors had sufficient value in estimating risk, there’s limited value for the moderate risk category - leading to nonspecific recommendations for aspirin use, a recognized prevention tool.    This cohort study of 5684 participants, culled from the multi-center Miracle of Life prospective study, found the guidelines ...

An FDA-backed metric used to determine effectiveness of rectal cancer drugs may be unreliable, says new study

2025-07-17
A new study by a Tulane University researcher casts doubt on a widely used shortcut in rectal cancer drug trials, raising concerns that some treatments may be fast-tracked for approval without evidence they help patients live longer. The study, published in JAMA Network Open in collaboration with researchers at Mayo Clinic in Arizona, found that the absence of detectable tumors after treatment – a key metric in clinical cancer drug trials known as pathologic complete response or pCR – does not reliably predict an improvement in long-term survival for patients diagnosed with ...

Research Spotlight: evaluating the effectiveness of guidelines to predict the risk of preeclampsia

2025-07-17
Q: How would you summarize your study for a lay audience? Dr. McElrath: Preeclampsia (PE) is a hypertensive disease that complicates 7-10% of pregnancies. While recent advances in understanding the underlying causes of PE have been made, predicting its occurrence has historically been difficult because it is a complex condition that likely results from a variety of causes and can present in different ways. To address this challenge, the United States Preventive Services Task Force (USPSTF) reviewed ...

Pigment researchers create vivid yellows, oranges, reds that are durable, non-toxic

2025-07-17
CORVALLIS, Ore. – Oregon State University pigment researchers are using a rare mineral discovered in Norway more than a century ago as a road map for creating new yellows, oranges and reds that are vibrant, durable, non-toxic and inexpensive. The new pigments also carry energy-saving potential: Their ability to reflect heat from the sun means that buildings and vehicles coated in them will require less air conditioning. The study led by Mas Subramanian, who made color history in 2009 with the discovery of a vivid blue pigment now known commercially as YInMn Blue, was published in Chemistry of Materials. Funded by the National Science Foundation, ...

Increased transparency about how countries use AI to manage migration needed, new study shows

2025-07-17
Increased transparency from countries about how they use AI to manage migration is needed to boost trust and strengthen the rule of law, a new study says. Any overuse of AI in migration management may perpetuate biases and errors, promoting excessive reliance on technology and undermining trust in decision‑making processes, an expert has warned. Adequate cybersecurity measures are also needed to protect sensitive data about vulnerable migrants. However, using AI for migrant management could present opportunities such as freeing up caseworkers’ time to focus on other critical areas, ...

Scientists repurpose old solar panels to convert CO2 exhaust into valuable chemicals

2025-07-17
Centuries ago, alchemists worked furiously to convert the common metal lead to valuable gold. Today, chemists are repurposing discarded solar panels to create valuable organic compounds from carbon dioxide (CO2), a common greenhouse gas. Significantly reducing greenhouse gasses in the atmosphere to mitigate the most devastating effects of climate change will require a large reduction in emissions as well as strategies designed to sequester emitted CO2 and other offending gasses. While simply sequestering ...

Epidemiology: Key predictors of avian flu outbreaks in Europe identified

2025-07-17
Several local factors — including the minimum temperature reached in autumn, the water level in lakes and ponds in winter, and the presence of mute swans (Cygnus olor) — could be key for predicting the potential of an outbreak of highly pathogenic avian flu (HPAI) occurring in Europe. The findings, published in Scientific Reports, are derived from a machine learning model trained on the characteristics of 21st century European HPAI outbreaks and could help improve future monitoring programmes. HPAI outbreaks are a serious concern for both animal and public health. A wave of HPAI outbreaks across the Northern Hemisphere during 2022 were associated with an ...

Global rise in many Early-Onset GI cancers detailed in two Dana-Farber reviews, with colorectal cancer leading the trend

2025-07-17
Boston, MA – July 17, 2025 – Early-onset gastrointestinal (GI) cancers are rising at alarming rates worldwide and, in the U.S., are increasing faster than any other type of early-onset cancer, including breast cancer, according to two recent literature reviews from Dana-Farber Cancer Institute. "Early-Onset Gastrointestinal Cancers: A Review," published today in JAMA, provides a comprehensive analysis of the incidence, risk factors, and treatment approaches for early-onset GI cancers. Authors note the rising rate goes ...

Cancer: COVID-19 boosters prevent hospitalizations

2025-07-17
Vaccine boosters help keep cancer patients from being hospitalized or admitted to intensive care units due to COVID-19, according to a new study led by Cedars-Sinai investigators. Their findings, published in JAMA Oncology, offer real-world evidence to support vaccine recommendations for these patients. “Cancer patients are a vulnerable population,” said Jane Figueiredo, PhD, director of Community Health and Population Research at Cedars-Sinai and senior author of the study. “Their immune systems can be weakened by their disease and the treatments they receive, ...

LAST 30 PRESS RELEASES:

Current and recommended diets in the USA have embedded forced labor risk

AI breakthrough helps astronomers spot cosmic events with just a handful of examples

New vaccine shows promise against typhoid and invasive salmonella in first human trial

Engineered “natural killer” cells could help fight cancer

New 3D printing method ‘grows’ ultra-strong materials

Lizard genetics provide new perspective on evolution

Can a Stevia-derived sweetener improve hair loss treatment?

Method to assess the status of wild reindeer may help with conservation efforts

Do imported cut flowers spread livestock viruses?

Does prior incarceration contribute to poor health later in life?

Could slime mold microbes be a source of potent antimicrobials?

Record-breaking 2024 Amazon fires drive unprecedented carbon emissions and ecosystem degradation

Birds thrive despite pollution from ‘forever’ chemicals

Deadwood brings wild orchids to life

Changes in gut microbiota influence which patients get AIG-related neuroendocrine tumors

Medicaid expansion linked to improved long-term survival in cancer patients

Women with surgical menopause may exit workforce earlier, but hormone therapy could help

Trailblazing Young Scientists honored with $250,000 prizes at Blavatnik National Awards Gala

Revolutionary blood test for ME / Chronic Fatigue unveiled

Calorie labelling linked to 2% average reduction in energy content of menu items

Widely prescribed opioid painkiller tramadol not that effective for easing chronic pain

Exercise snacks may boost cardiorespiratory fitness of physically inactive adults

15,000 women a year with breast cancer could benefit from whole genome sequencing, say researchers

Study highlights risks of Caesarean births to future pregnancies

GLP-1 agonists pose emerging challenge for PET-CT imaging, study finds

Scripps Research scientists unlock new patterns of protein behavior in cell membranes

Panama Canal may face frequent extreme water lows in coming decades

Flash Joule heating lights up lithium extraction from ores

COMBINEDBrain and MUSC announce partnership to establish biorepository for pediatric cerebrospinal fluid and CNS tissue bank

Questionable lead reporting for drinking water virtually vanished after Flint water crisis, study reveals

[Press-News.org] Research Spotlight: Study reveals an unexpected role for protein aggregates in brain disease
Researchers from Mass General Brigham release a new study linking protein aggregation to altered RNA processing in genetic forms of neurodegeneration